BlackBerry will re-start monetisation of remaining patents if sale closes this quarter
CEO John Chen says company will use a third party to extract value from 2,000 patents it is keeping
CEO John Chen says company will use a third party to extract value from 2,000 patents it is keeping
Reported DG Grow proposals designed to make FRAND dealmaking in Europe more transparent, predictable and efficient are one-sided and poorly thought-through, so will do much more harm than good
J&J subsidiary makes innovative use of IP acquired in $6.5 billion Momenta acquisition
Brand owners are advised to weigh up their business needs when deciding whether to file a national application with the CNIPA or for international registration through the Madrid Protocol (designating China).
24 August 2022
Imperial College tech transfer chief Vjera Magdalenic-Moussavi says the recent legislation puts dealmaking in danger
23 August 2022
The chipmaker spawned the term “patent troll” and has been highly critical of NPEs, but negative business headwinds mean that putting its world-class portfolio of IP assets to work is a no brainer
19 August 2022
Several approaches have emerged under this banner, each offering advantages and disadvantages
15 August 2022
The unfolding legal dispute between the ubiquitous social media giant and the billionaire with 100 million followers is set to become the legal battle of the year when it hits court in October
13 August 2022
With significant revenue drop-offs from existing branded products set to decline steeply in the second half of this decade, major portfolio acquisitions are a priority for both companies
10 August 2022
The Asia-Pacific region’s premier event about the business of IP will take place in the Japanese capital from 31 October to 2 November
10 August 2022
The portfolio covers a wide range of the tech produced by the Silicon Valley giant and will now be monetised by an entity named Tahoe Research Limited
08 August 2022
No commonly used valuation methods are much help at putting a number on an entire portfolio unless there is a specific transaction on the horizon. Cipher’s Nigel Swycher and Steve Harris suggest an original methodology to fill this gap
03 August 2022
The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months
29 July 2022
Unlock unlimited access to all IAM content